Clinical study of 73 local-advanced nasopharyngeal carcinoma patients treated with chemoradiotherapy
Xue-cheng ZHANG,Mei SHI,Feng XIAO,Li-chun WEI,Chao-yang SUN,Yong ZHU,Jun LU,Xiao-li LIU
DOI: https://doi.org/10.3969/j.issn.1673-5269.2007.22.010
2007-01-01
Abstract:Objective: To present preliminary results of two different chemoradiotherapy schemes in patients with nasopharyngeal carcinoma and to observe the acute and late normal tissue toxicities. Methods: There were 73 patients with nasopharyngeal carcinoma. All the patients were divided into 2 groups, (RT + CT) group 42 cases, and (IMRT + CT) group 31 cases. For conventional radiation technique, the prescription dose to the target was (70 - 76) Gy. For IMRT, the prescription dose was engaged to the gross tumor volume (GTVnx) of nasopharyngeal to DT (70.6 - 76.6) Gy/(31 - 33) f, positive neck lymph nodes (GTVnd) to DT (61.6 - 70.6) Gy/(28 - 33) f, clinical target volume high risk (CTV1) to 56 Gy/28 f, and low risk (CTV2) to (50.4 - 53.2) Gy/28 f. The chemotherapy was included induction, concomitant and adjuvant protocol. Results: With a median followed-up of 20 months. In all patients, the 2-, 3-year estimated local-regional progression-free survival rates, distant metastases-free survival rates and overall survival rates were 83.3%, 90.9%, 86.2% and 78.9%, 89.5%, 84.3%, respectively. In (RT + CT) group, they were 70.0%, 85.0%, 77.6% and 70.0%, 80.6%, 60.4%, respectively. In (IMRT + CT) group, they were 88.9%, 95.5%, 100% and 88.9%, 95.5%, 100%, respectively. (IMRT + CT) group had significantly higher local-regional progression-free survival rate and overall survival rate than (RT + CT) group (P = 0.045, P = 0.021). Conclusion: IMRT combined with chemotherapy can improve local-regional progression-free survival rate and overall survival rate of patients with local-advanced nasopharyngeal carcinoma.